Share your videos with the world

Consumers who choose a 2017 TOP SAFETY PICK+ award winner shouldn’t have trouble seeing the road on nighttime drives. Good or acceptable ratings in the Insurance Institute for Highway Safety’s new headlight evaluations set the latest crop of qualifiers apart. Thirty-eight models earn the “plus” accolade, and 44 earn TOP SAFETY PICK. IIHS toughened the criteria for TOP SAFETY PICK+ to reflect new headlight evaluations launched in 2016. The recognition program is meant to encourage manufacturers to offer state-of-the-art protection for people in crashes, along with features that help drivers avoid crashes in the first place. In addition to good or acceptable headlights, the latter includes automatic braking technology, which has been part of the criteria since 2015. For both awards, models must earn good ratings in the Institute’s small overlap front, moderate overlap front, side, roof strength and head restraint tests, as well as an advanced or superior rating for front crash prevention with standard or optional autobrake. Headlights are factored in only for the top award.

Online Learning Guideline process. ACRI is the only institute to incorporate activity based learning methodology. Our students are placed in highly reputed firms and have been recognized for their extensive knowledge in the field of Clinical Research Reach us : acriindia.com/about-acri

Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children’s Research Hospital and at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results of this study appear today in the journal Science Translational Medicine. The study involved five males with X-linked severe combined immunodeficiency disease (SCID-X1), also known as “Bubble Boy” disease, who were all treated at NIAID. This inherited disorder involves a mutation in the IL2RG gene that affects males and occurs in 1 of every 50,000 to 100,000 live births, leaving them with little to no immune protection. To view the multimedia release go to: http://www.multivu.com/players/English/7808651-st-jude-gene-therapy-results/

Avigna Clinical Research Institute is modeled on the lines of some of the premier Clinical Research Institutes of India. We are dedicated and committed to provide excellent Clinical Research Professionals to the Clinical Research Industries.

In this video shanthala Avigna clinical research student talking about teaching, placement and excellent facility provided to students in all aspects to reach their goal.